Skip to main content
Fig. 1 | Arthritis Research & Therapy

Fig. 1

From: Mepolizumab exerts crucial effects on glucocorticoid discontinuation in patients with eosinophilic granulomatosis with polyangiitis: a retrospective study of 27 cases at a single center in Japan

Fig. 1

Clinical indicators and GC dose at diagnosis of EGPA and pre and post mepolizumab initiation. P values were determined by Wilcoxon signed-rank test. P < 0.05: baseline (at the diagnosis) vs. pre-MPZ, pre-MPZ vs. post-MPZ. MPZ mepolizumab, BVAS Birmingham Vasculitis Activity Score, PSL prednisolone

Back to article page

Arthritis Research & Therapy

ISSN: 1478-6362

Contact us